Scientists At National Cancer Institute Target Hepatocellular Cancer

Researchers detail in 'Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle,' new data in hepatocellular cancer. According to a study from Milan, Italy, The advent of molecular medicine that targets specific pathways is changing the therapeutic approach to hepatocellular carcinoma.